Abstract. Thrombocytopenia is a common finding in malaria, but its prognostic value has not been addressed in children. The relationship between thrombocytopenia (platelet count < 100,000/mm 3 on admission) and severity and outcome was investigated prospectively in children hospitalized with falciparum malaria in Dakar, Senegal, an area that is hypoendemic for malaria. Of 288 falciparum cases, 215 matched the 2000 World Health Organization definition of severe malaria. Median platelet counts were lower (98,000/mm 3 versus 139,000/mm 3 ; P < 0.02) among severe cases than in mild cases, and in children who died than among those who recovered (68,500/mm 3 versus 109,000/mm 3 ; P < 0.002). In severe cases, children presenting with a platelet count < 100,000/mm 3 were more likely to die (odds ratio [OR] ‫ס‬ 6.31, 95% confidence interval [CI] ‫ס‬ 2.0-26.0). Moreover, multivariate analysis identified thrombocytopenia as an independent predictor of death (OR ‫ס‬ 13.3, 95% CI ‫ס‬ 3.2-55.1). Our data show an association between thrombocytopenia and either severity or prognosis in childhood falciparum malaria.
INTRODUCTION
Thrombocytopenia is common among people indigenous to the tropics, 1,2 and non-immune subjects [3] [4] [5] infected by Plasmodium falciparum or P. vivax. In tropical areas, malaria has been reported as one of the major causes of low platelet counts. 6 Malaria-related thrombocytopenia may result from either a decrease in platelet production or an increased platelet turnover due to different mechanisms of destruction. A central mechanism is unlikely since increased numbers of megakaryocytes are found in patients with acute malaria. 7, 8 There are converging arguments in favor of immunemediated destruction, 7,9-11 platelet activation, 2, 6, 11 removal by the reticuloendothelial system 2, 7, 12 or consumption in different steps of coagulation. 1, 13 Disseminated intravascular coagulopathy is now considered quite rare. 2, 3, 11, 14 Although platelet invasion by malarial parasites 15 and platelet phagocytosis 16 have been reported, it appears to have little clinical relevance. 17 These mechanisms, which were studied mostly in adults, may coexist in a patient and interfere with each other. 14, 17 Little attention has been paid to platelets in series of African pediatric malaria patients. Data from some pediatric field 18, 19 and pathologic studies 20 suggest that platelets play an important role in the pathophysiology of severe malaria, especially with cerebral involvement. Thus platelet sequestration was seen in cerebral microvessels of children who died of cerebral malaria in Thailand 20 and Malawi (Grau GE et al., personal communication) . We therefore investigated the prognostic significance of thrombocytopenia in African children with falciparum malaria living in Dakar, Senegal, where transmission is low and seasonal. 21 Our results emphasize the usefulness of thrombocytopenia in predicting fatal falciparum malaria.
MATERIALS AND METHODS
Study area and population. The study took place in the pediatric department of the Hôpital Principal in Dakar, Senegal from October 1, 1997 to March 31, 1999 . This hospital is one of the three main hospitals in Dakar and it serves a predominantly urban population. It has been managed for more than 100 years by French military physicians specializing in tropical medicine and is partly supported by the French Ministry of Co-operation. Approximately 3,500 children are admitted annually to its 120-bed pediatric ward.
All children (0-15 years old) with clinical signs of malaria and a P. falciparum-positive thick blood film were prospectively enrolled to assess prognostic factors of childhood malaria in this setting of low and seasonal transmission. Clinical and biological data were collected for medical management. Informed consent was obtained from first-degree relatives, according to the recommendations of the Ethical Committee of Hôpital Principal.
Laboratory procedures. On admission, children were weighed and blood was withdrawn for following measurements. Parasitemia (percentage of infected red blood cells estimated on Giemsa-stained blood thin smears), hematocrit and hemoglobin rates, mean corpuscular volume (designated as an indicator of iron deficiency if less than 75 fl 3 ), and complete blood cell count were determined by ST KS Coultronics automation (Coulter Inc, Miami, Florida, USA). Blood glucose, bilirubin, urea, and creatinine were measured by the RA 1000 method (Bayer, Leverkusen, Germany). Electrolytes were measured using flame emission spectrophotometry by the IL 943 method (Instrument Laboratory, Milano, Italy). Plasma bicarbonate concentrations and arterial pH were determined by the AVL 990 method (Roche, Basel, Switzerland).
Platelets were counted from a whole blood sample by ST KS Coultronics automation. Thrombocytopenia was first defined as a platelet count less than 150,000/mm 3 . In case of severe thrombocytopenia (platelet counts less than 20,000/ mm 3 ) or hemorrhage, citrate tube and blood coagulation tests (for prothrombin time, partial thromboplastin time, and fibrinogen) were performed using manual chronometric tests.
Clinical assessment. The presence of 1990 World Health Organization (WHO) severity criteria 22 or respiratory distress 23 was systematically documented by a physician on ad hoc designed forms that also allowed the definition of severe cases using 2000 WHO guidelines fever, severe sepsis, pneumonia. The state of consciousness was assessed using the Blantyre coma scale, 22 and the revised Glasgow coma scale (scores of 3 to 15), 24 which is widely used in French pediatric intensive care units. Prostration (Blantyre score ‫ס‬ 5 and Glasgow score ‫ס‬ 15, but an inability to sit or drink), impaired consciousness (Blantyre score > 3 and < 5, or a Glasgow score > 9 and < 15), or cerebral malaria (unrousable coma with a Blantyre score Յ 3 or a Glasgow score Յ 9) were considered present if symptoms persisted more than one hour after a seizure or administration of an anticonvulsivant drug. Hyperparasitemia was defined according to the 2000 WHO criteria 17 in this area of low transmission beyond the cut-off value of 4% of the red blood cells. Neurologic sequelae were assessed at discharge.
Case management. Children with severe malaria were treated following the 1990 WHO guidelines. 22 Quinine formate (10 mg/kg salt, e.g., 8.3 mg/kg base) was infused intravenously every eight hours for 2-3 days, followed by oral chloroquine (25 mg/kg for 3 days). No loading dose of quinine was given because of frequent undocumented treatments prior to admission. In cases of cerebral malaria or multiple convulsions, a loading dose of 5-15 mg/kg of phenobarbital was given by slow intravenous infusion. If that failed, escalating doses of continuously infused clonazepam were given. Thiopental was given as a last resort. Comatose children with a Blantyre coma score Յ 2 or a Glasgow coma score Յ 7, seizures requiring thiopental, or severe collapse were intubated and mechanically ventilated. Whole blood transfusions for severe anemia (hemoglobin < 5 g/dL or a hematocrit < 15%) were restricted to children with respiratory distress. After rehydration and parenteral furosemide, severe persistent renal failure was treated with hemodialysis.
Statistical analysis. Clinical and biological data from the first 24 hours of hospitalization were computed for univariate and multivariate analysis using Stata (Stata Statistical Software: release 7, 2001; Stata Corp., College Station, TX), considering two possible outcomes, i.e., alive or dead. Proportions were compared by chi-square or Fisher exact tests. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for the risk of death. Because of the skewed distribution of platelet counts, distributions were compared using the Kruskal-Wallis or Mann-Whitney tests. A P value < 0.05 was considered statistically significant.
Since there were no deaths in prostrated patients, prostration and impaired consciousness were grouped and designated as a light cerebral disorder. In subsequent analysis, the level of consciousness was divided in three classes: normal, light cerebral disorder, and cerebral malaria.
The predictive value of thrombocytopenia for the risk of death was estimated in cases with cerebral malaria, respiratory distress, severe anemia, or any case considered severe by the 2000 WHO criteria.
The effect of thrombocytopenia was estimated in a multivariate logistic regression model adjusting for severe malaria by the 2000 WHO criteria. Because the number of cases presenting with renal failure, collapse, abnormal bleeding, or pulmonary edema was too low, these clinical variables were collapsed in a dichotomous variable taking the value "present" when any of them were present and the value "absent" when all of them were absent. Since plasma bicarbonate concentrations were not tested in some patients without any clinical sign suggesting acidosis, they were considered as normal in the multivariate analysis.
All the interaction terms between the variables included in the model were tested. The adequacy of the models was tested by the Hosmer and Lemeshow goodness of fit test.
RESULTS
Population characteristics. From October 1, 1997 to March 31, 1999, 319 consecutive children were hospitalized with falciparum malaria. Among them, 288 had platelet counts recorded on admission time and were eligible for the present study, of whom 215 (74.7%) had severe falciparum malaria according to the WHO 2000 criteria, and 73 (25.3%) had a mild form. The median age was 7.5 years (Inter-quartile interval (IQ) 25-75% ‫ס‬ 5-11 years), and the sex ratio (male: female ‫ס‬ 168 :120) was 1.4. Outcome was recovery without sequelae (n ‫ס‬ 249; 86.5%) or with neurologic sequelae upon discharge (n ‫ס‬ 13; 4.5%), or death (n ‫ס‬ 26; 9%).
Univariate analysis of platelets, severity, and outcome. The frequencies of 2000 WHO severe malaria criteria and the distributions of platelet counts according to clinical presentations are shown in Table 1 . The median platelet count was 105,000/mm 3 (IQ 25-75% ‫ס‬ 60,000-188,000/mm 3 ). No disseminated intravascular coagulopathy was found in patients with abnormal bleeding. Low platelet counts were not statistically associated with abnormal bleeding.
Distribution of clinical forms, age, parasitemia, and evolution of disease according to admission platelet counts are shown in Table 2 . Platelet counts were inversely related to age and parasitemia. Thrombocytopenia was significantly more frequent and more profound in those with severe malaria than in those with mild forms. Platelet counts were significantly lower in children who died than among those who recovered, but did not differentiate between survivors with or without neurologic sequelae. When the risk of death was compared between thrombocytopenic and non-thrombocytopenic patients, it was significantly increased among children with platelet counts less than 100,000/mm 3 (15.9%, 22 of 138; OR ‫ס‬ 6.13, 95% CI ‫ס‬ 1.7-32.8, P < 0.005), but was not increased among those with platelet counts between 100,000 and 150,000/mm 3 (2%, 1 of 50; OR ‫ס‬ 0.66, 95% CI ‫ס‬ 0.01-8.5, P ‫ס‬ 0.86; Table 3 ).
Consequently, the cut-off value of 100,000/mm 3 was retained to assess the relationship between thrombocytopenia and outcome in further analysis. So defined, thrombocytopenia tended to be more frequent (51.2% versus 38.4%; P ‫ס‬ 0.10) in severe cases than in mild cases.
Relationships between thrombocytopenia and the risk of death among severe malaria groups are shown in Table 3 . Thrombocytopenia was associated with an increased risk of death in severe cases (OR ‫ס‬ 6.3, 95% CI ‫ס‬ 2.0-26.0). In these cases, platelet counts less than 100,000/mm 3 had positive and negative predictive values of 20% and 96%, respectively, in predicting fatality (Table 3 ). In those with cerebral malaria, thrombocytopenia was more frequent (71.4% versus 37.5%; P < 0.003) and pronounced (median platelet count ‫ס‬ 79,000/mm 3 versus 128,000/mm 3 ; P < 0.02) among children who died than in those who recovered.
Mutivariate analysis of thrombocytopenia and predictors of outcome. Logistic regression models identified thrombocytopenia as an independent predictor of death (Table 4) . When the effect of light cerebral disorders, cerebral malaria, respiratory distress syndrome, severe anemia and other severe malaria criteria was taken into account, the risk of death was increased (OR ‫ס‬ 13.3, 95% CI ‫ס‬ 3.2-55.1) when platelet counts were less than 100,000/mm 3 . No interaction among the variables included in the model was significant. When we controlled for clinical factors, age was not associated with fatality. The effect of thrombocytopenia on lethality was not affected by gender, age, parasitemia, or presumed iron deficiency. An analysis restricted to patients in whom the bicarbonate concentration was determined shown similar results.
DISCUSSION
Thrombocytopenia has rarely been studied in tropical pediatric malaria. Its prevalence may be rare in holoendemic settings. 6 To our knowledge, it has not been assessed before in hypoendemic areas. In Dakar, a low and seasonal transmission area, we found a platelet count less than 150,000/mm 3 in 56.2% of clinical malaria cases admitted with no WHO severe criterion. This prevalence rate is higher than the 13-46% observed in children returning from the tropics with falciparum malaria, 4, 25 and similar to rates reported in adults infected with P. vivax or P. falciparum, whether traveling (60-80%) 3, 5, 9 or living in seasonal transmission areas (57-66%).
1,2 However, platelet counts have never been reported in severe pediatric forms, except for a small Senegalese series. 26 Our results show that thrombocytopenia is more frequent and more profound in severe forms than in mild forms. Whatever the clinical presentation, it is predictive of fatal outcome.
In this study, the relevance of thrombocytopenia in predicting poor outcome in children with falciparum malaria relies upon several converging arguments. 1) The median platelet count was significantly decreased in severe malaria, irrespective of severe disease features. 2) Children who died had admission platelet counts lower than those who recovered. 3) In severe cases, platelet counts less than 100,000/mm 3 had a negative predictive value in predicting a fatal outcome of 96%. 4) Multivariate analysis identified thrombocytopenia as an independent predictor of death.
Presumed iron deficiency, a frequent confounding factor that enhances platelet production, 27 was unlikely to interfere in our study since we found no association between the mean corpuscular volume and either thrombocytopenia or lethality.
Thrombocytopenia, even when severe, was not statistically associated with abnormal bleeding. The good tolerance of low platelet counts is well known in malaria. 2, 17 It could be explained by platelet activation 2, 6 and an enhanced aggregability. 11, 28 Although the purpose of this study was not to determine the mechanisms of malaria-related thrombocytopenia, the results can be interpreted in light of several issues involving platelets in patients with severe malaria. The negative association between age and platelet counts could support the involvement of immune mechanisms in the pathogenesis of thrombocytopenia. 7, [9] [10] [11] Another important issue could be the negative association between parasitemia and platelet counts, another finding previously reported in small series of patients. 2, 26 Little attention has been paid to circulating platelets in severe malaria. Nevertheless, there are convincing arguments from in vitro studies, experiments with murine models, and recent field studies that implicate platelets in the pathogenesis of cerebral malaria. 1) Platelets are able to inhibit P. falciparum growth by direct toxicity. 29 2) In a mouse model of cerebral malaria, sequestrated platelets are critical effectors of brain microvascular pathology and antiplatelet therapy can improve outcome. 30 3) The extent of thrombocytopenia is a hallmark of forthcoming death in mice, a condition also observed in humans. 31 4) In humans, platelet counts were inversely correlated with levels of tumor necrosis factor-␣, a major factor involved in the pathogenesis of severe malaria. 26 5) Low expression of platelet CD36 was recently shown to be associated with susceptibility to cerebral malaria and poor outcome in the Gambia and Kenya. 18 6) Lastly, plateletmediated clumping of P. falciparum-infected erythrocytes, a common adhesive phenotype observed in Kenyan population, was associated with severity. 19 Platelets are likely to be involved in immune mechanisms of cerebral malaria. 32, 33 There is convincing pathologic evidence of platelet sequestration in cerebral microvessels, both in mice 30, 31 and in children who died of cerebral malaria in Thailand 20 and Malawi (Grau GE et al., personal communication). This phenomenon might partially explain, in our survey, the significance of a platelet count less than 100,000/mm 3 in predicting death, especially in cases of neurologic involvement.
In conclusion, our findings indicate a significant prognostic value of falciparum malaria-related thrombocytopenia among African children living in a low and seasonal transmission setting. The role of platelets in the pathogenesis of severe malaria should be further investigated in future studies.
